Načítá se...
5-Year Outcomes with Anti-VEGF Treatment of Neovascular Age-related Macular Degeneration (AMD): The Comparison of AMD Treatments Trials
PURPOSE: To describe outcomes 5 years after initiation of treatment with bevacizumab or ranibizumab for neovascular age-related macular degeneration (AMD). DESIGN: Cohort study.. PARTICIPANTS: Patients enrolled in the Comparison of AMD Treatments Trials (CATT). METHODS: Patients were randomly assign...
Uloženo v:
| Vydáno v: | Ophthalmology |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4958614/ https://ncbi.nlm.nih.gov/pubmed/27156698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.03.045 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|